Serum S100B Protein is Specifically Related to White Matter Changes in Schizophrenia
Open Access
- 8 March 2016
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Cellular Neuroscience
Abstract
Background: Schizophrenia can be conceptualized as a form of dysconnectivity between brain regions. To investigate the neurobiological foundation of dysconnectivity, one approach is to analyze white matter structures, such as the pathology of fiber tracks. S100B is considered a marker protein for glial cells, in particular oligodendrocytes and astroglia, that passes the blood brain barrier and is detectable in peripheral blood. Earlier Studies have consistently reported increased S100B levels in schizophrenia. In this study, we aim to investigate associations between S100B and structural white matter abnormalities. Methods: We analyzed data of 17 unmedicated schizophrenic patients (first and recurrent episode) and 22 controls. We used voxel based morphometry (VBM) to detect group differences of white matter structures as obtained from T1-weighted MR-images and considered S100B serum levels as a regressor in an age-corrected interaction analysis. Results: S100B was increased in both patient subgroups. Using VBM, we found clusters indicating significant differences of the association between S100B concentration and white matter. Involved anatomical structures are the posterior cingulate bundle and temporal white matter structures assigned to the superior longitudinal fasciculus. Conclusions: S100B-associated alterations of white matter are shown to be existent already at time of first manifestation of psychosis and are distinct from findings in recurrent episode patients. This suggests involvement of S100B in an ongoing and dynamic process associated with structural brain changes in schizophrenia. However, it remains elusive whether increased S100B serum concentrations in psychotic patients represent a protective response to a continuous pathogenic process or if elevated S100B levels are actively involved in promoting structural brain damage.This publication has 72 references indexed in Scilit:
- Validating Serum S100B and Neuron-Specific Enolase as Biomarkers for the Human Brain – A Combined Serum, Gene Expression and MRI StudyPLOS ONE, 2012
- Astrocyte and Glutamate Markers in the Superficial, Deep, and White Matter Layers of the Anterior Cingulate Gyrus in SchizophreniaNeuropsychopharmacology, 2011
- Adipocytes as an Important Source of Serum S100B and Possible Roles of This Protein in Adipose TissueCardiovascular Psychiatry and Neurology, 2010
- White matter defects in first episode psychosis patients: A voxelwise analysis of diffusion tensor imagingNeuroImage, 2010
- Meta-analysis of diffusion tensor imaging studies in schizophreniaSchizophrenia Research, 2009
- The Anatomy of First-Episode and Chronic Schizophrenia: An Anatomical Likelihood Estimation Meta-AnalysisAmerican Journal of Psychiatry, 2008
- Disturbed Structural Connectivity in Schizophrenia Primary Factor in Pathology or Epiphenomenon?Schizophrenia Bulletin, 2007
- What Happens After the First Episode? A Review of Progressive Brain Changes in Chronically Ill Patients With SchizophreniaSchizophrenia Bulletin, 2007
- Early Activation of Extracellular Signal-Regulated Kinase Signaling Pathway in the Hippocampus is Required for Short-Term Memory Formation of a Fear-Motivated LearningCellular and Molecular Neurobiology, 2006
- Failure to find progressive temporal lobe volume decreases 10 years subsequent to a first episode of schizophreniaPsychiatry Research: Neuroimaging, 2005